NASDAQ:VIR

Vir Biotechnology Stock Insider Trading

etoro logo Buy VIR
*Your capital is at risk
$8.66
-0.240 (-2.70%)
At Close: Jul 31, 2026

Vir Biotechnology Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -79.72. In total, the insiders bought 1.92M and sold 5.04M VIR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-79.72
Buy 1.92M shares
Sell 5.04M shares
30% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Apr 29, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -79.72.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 22, 2026
Buy
Common Stock
A-Award
Sabatini Brent
SVP, Chief Accounting Officer
Officer 25 000
Value: $216.5K
Feb 22, 2026
Buy
Stock Option (Right to Buy)
A-Award
Eisner Mark
EVP And Chief Medical Officer
Officer 110 000
Value: $831.6K
Feb 22, 2026
Buy
Common Stock
A-Award
De Backer Marianne
Chief Executive Officer
CEO / President 285 000
Value: $2.47M
Feb 22, 2026
Buy
Stock Option (Right to Buy)
A-Award
De Backer Marianne
Chief Executive Officer
CEO / President 570 000
Value: $4.31M
Feb 13, 2026
Sell
Common Stock
S-Sale
Sabatini Brent
SVP, Chief Accounting Officer
Officer 1 530
Value: $11.9K
Feb 02, 2026
Sell
Common Stock
S-Sale
Sato Vicki L
Director
Director 22 000
Value: $169.7K
Jan 02, 2026
Sell
Common Stock
S-Sale
Sato Vicki L
Director
Director 22 000
Value: $130.4K
Dec 01, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 191 854
Value: $1.15M
Dec 01, 2025
Sell
Common Stock
S-Sale
Sato Vicki L
Director
Director 22 000
Value: $132.1K
Nov 28, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 61 493
Value: $396.0K
Nov 26, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 127 938
Value: $817.7K
Nov 25, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 235 971
Value: $1.51M
Nov 24, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 227 803
Value: $1.40M
Nov 17, 2025
Sell
Common Stock
S-Sale
O'byrne Jason
EVP & Chief Financial Officer
C-Suite Officer 6 799
Value: $37.8K
Nov 05, 2025
Sell
Common Stock
S-Sale
De Verneuil Vanina
EVP, General Counsel, Corp Sec
Officer 2 385
Value: $12.3K
Nov 03, 2025
Sell
Common Stock
S-Sale
De Verneuil Vanina
EVP And General Counsel
Officer 1 365
Value: $8K
Nov 03, 2025
Sell
Common Stock
S-Sale
Sato Vicki L
Director
Director 22 000
Value: $124.0K
Oct 29, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 100
Value: $649
Oct 28, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 24 453
Value: $159.0K
Oct 27, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 66 403
Value: $401.6K
Oct 24, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 46 696
Value: $278.3K
Oct 23, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 154 383
Value: $924.7K
Oct 22, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 144 266
Value: $887.7K
Oct 21, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 109 675
Value: $691.0K
Oct 20, 2025
Sell
Common Stock
S-Sale
Svf Endurance (cayman) Ltd
10 Percent Owner
10% Owner 220 535
Value: $1.37M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VIR BIOTECHNOLOGY, INC.
Vir Biotechnology
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus....
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE